181 related articles for article (PubMed ID: 38101039)
1. Targeting phosphatases: From molecule design to clinical trials.
Guo M; Li Z; Gu M; Gu J; You Q; Wang L
Eur J Med Chem; 2024 Jan; 264():116031. PubMed ID: 38101039
[TBL] [Abstract][Full Text] [Related]
2. Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer.
Zhang Q; Fan Z; Zhang L; You Q; Wang L
J Med Chem; 2021 Jul; 64(13):8916-8938. PubMed ID: 34156850
[TBL] [Abstract][Full Text] [Related]
3. Meeting Report Europhosphatase 2015: Phosphatases as Drug Targets in Cancer.
Hoekstra E; Peppelenbosch MP; Fuhler GM
Cancer Res; 2016 Jan; 76(2):193-6. PubMed ID: 27309387
[TBL] [Abstract][Full Text] [Related]
4. Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation.
Miao J; Zhang ZY
ChemMedChem; 2024 Apr; 19(7):e202300669. PubMed ID: 38233347
[TBL] [Abstract][Full Text] [Related]
5. A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation.
Rice RL; Rusnak JM; Yokokawa F; Yokokawa S; Messner DJ; Boynton AL; Wipf P; Lazo JS
Biochemistry; 1997 Dec; 36(50):15965-74. PubMed ID: 9398331
[TBL] [Abstract][Full Text] [Related]
6. Viewing serine/threonine protein phosphatases through the eyes of drug designers.
Zhang M; Yogesha SD; Mayfield JE; Gill GN; Zhang Y
FEBS J; 2013 Oct; 280(19):4739-60. PubMed ID: 23937612
[TBL] [Abstract][Full Text] [Related]
7. Strategies to make protein serine/threonine (PP1, calcineurin) and tyrosine phosphatases (PTP1B) druggable: achieving specificity by targeting substrate and regulatory protein interaction sites.
Peti W; Page R
Bioorg Med Chem; 2015 Jun; 23(12):2781-5. PubMed ID: 25771485
[TBL] [Abstract][Full Text] [Related]
8. Targeting protein serine/threonine phosphatases for drug development.
McConnell JL; Wadzinski BE
Mol Pharmacol; 2009 Jun; 75(6):1249-61. PubMed ID: 19299564
[TBL] [Abstract][Full Text] [Related]
9. Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives.
Liu R; Mathieu C; Berthelet J; Zhang W; Dupret JM; Rodrigues Lima F
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806030
[TBL] [Abstract][Full Text] [Related]
10. The therapeutic potential of phosphatase inhibitors.
Vintonyak VV; Antonchick AP; Rauh D; Waldmann H
Curr Opin Chem Biol; 2009 Jun; 13(3):272-83. PubMed ID: 19410499
[TBL] [Abstract][Full Text] [Related]
11. Targeting Tyrosine Phosphatases: Time to End the Stigma.
Stanford SM; Bottini N
Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Virtual Screening of Protein Tyrosine Phosphatase Inhibitors: Significance, Challenges, and Solutions.
Reddy RH; Kim H; Cha S; Lee B; Kim YJ
J Microbiol Biotechnol; 2017 May; 27(5):878-895. PubMed ID: 28238001
[TBL] [Abstract][Full Text] [Related]
13. Development of fluorescence-based selective assays for serine/threonine and tyrosine phosphatases.
Pastula C; Johnson I; Beechem JM; Patton WF
Comb Chem High Throughput Screen; 2003 Jun; 6(4):341-6. PubMed ID: 12769677
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.
Gao PP; Qi XW; Sun N; Sun YY; Zhang Y; Tan XN; Ding J; Han F; Zhang Y
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188562. PubMed ID: 33964330
[TBL] [Abstract][Full Text] [Related]
15. Dual function of protein phosphatase 5 (PPP5C): An emerging therapeutic target for drug discovery.
Zhang H; Zhang Q; Tu J; You Q; Wang L
Eur J Med Chem; 2023 Jun; 254():115350. PubMed ID: 37054560
[TBL] [Abstract][Full Text] [Related]
16. Do metabolic HAD phosphatases moonlight as protein phosphatases?
Gohla A
Biochim Biophys Acta Mol Cell Res; 2019 Jan; 1866(1):153-166. PubMed ID: 30030002
[TBL] [Abstract][Full Text] [Related]
17. The relationship between the MMP system, adrenoceptors and phosphoprotein phosphatases.
Rietz A; Spiers J
Br J Pharmacol; 2012 Jun; 166(4):1225-43. PubMed ID: 22364165
[TBL] [Abstract][Full Text] [Related]
18. Discovery of protein kinase phosphatase inhibitors.
Vogt A; Lazo JS
Methods Mol Biol; 2007; 356():389-400. PubMed ID: 16988418
[TBL] [Abstract][Full Text] [Related]
19. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Stanford SM; Bottini N
Nat Rev Drug Discov; 2023 Apr; 22(4):273-294. PubMed ID: 36693907
[TBL] [Abstract][Full Text] [Related]
20. The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte.
Taylor BS; Liu S; Villavicencio RT; Ganster RW; Geller DA
Hepatology; 1999 Apr; 29(4):1199-207. PubMed ID: 10094965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
